To clarify the mechanisms of ZHX2 affecting the sensitivity of myeloma cell to BTZ, we determined NF‐κB expression in cytoplasm and nucleus after ZHX2 knock‐down. The gene discussed is NFKB1; the disease is plasma cell myeloma.